Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Equity Ratio (2019 - 2025)

AVITA Medical's Equity Ratio history spans 7 years, with the latest figure at 0.3 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 623.12% year-over-year to 0.3; the TTM value through Dec 2025 reached 0.3, down 623.12%, while the annual FY2025 figure was 0.3, 623.12% down from the prior year.
  • Equity Ratio reached 0.3 in Q4 2025 per RCEL's latest filing, down from 0.1 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2021 to a low of 0.3 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.51, with a median of 0.79 recorded in 2023.
  • Peak YoY movement for Equity Ratio: increased 5.96% in 2021, then tumbled 623.12% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.9 in 2021, then dropped by 4.37% to 0.86 in 2022, then crashed by 49.05% to 0.44 in 2023, then tumbled by 87.16% to 0.06 in 2024, then plummeted by 623.12% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Equity Ratio are 0.3 (Q4 2025), 0.1 (Q3 2025), and 0.22 (Q2 2025).